ERS International Congress, Milan 2017

---

Pleural and mediastinal malignancies

Thematic Poster
Chairs: K. Blyth (Glasgow, United Kingdom), J. Janssen (Nijmegen, Netherlands), K. Lamote (Wilrijk, Belgium), S. Zarogiannis (Larisa, Greece)

TGF-ß participates in epithelial-mesenchymal transition in pleural fibrosis via targeting S100A4 Z. Sun (China)
Gender differences in asbestos exposure and disease location in 327 patients with mesothelioma J. Bak (Randers, Denmark)
The axis of ?MGB1 and soluble RAGE levels in pleural effusions from various etiologies. O. Kotsiou (Larisa, Greece)
Evaluation of New Biomarkers in Prediction of Malignant Mesothelioma in Subjects with Environmental Asbestos Exposure M. Demir (DIYARBAKIR, Turkey)
Can suspicion for malignancy improve the indication of video-assisted thoracoscopic surgery (VATS) in patients with pleural effusion of unknown cause? T. Aiello (Barcelona, Spain)
Imaging in Pleural Infections: The Radiation Adds Up C. Wilshire (Seattle, United States of America)
Equalisation of negative intra-pleural pressure via Tunnelled Pleural Catheters (TPCs): a novel practice. A. Ewence (Salisbury, United Kingdom)
The role of Epithelial sodium channel (ENaC) in cell proliferation and tunneling nanotube (TnT) formation in benign mesothelial cells and malignant pleural mesothelioma (MPM) cells. O. Kotsiou (Larisa, Greece)
Tunnelled indwelling pleural catheters and trapped lung in malignant mesothelioma Y. Madani (London, United Kingdom)
Inflammatory appearance of the parietal pleura at thoracoscopy – what does it hide? Y. Madani (London, United Kingdom)
Alternative way of tunneling a pleural catheter using a single puncture - our experiences, safety and effectivity. D. Havel (Plzen 1, Czech Republic)
Current etiological profile of clear liquid exudative pleural effusion H. Smadhi (ARIANA, Tunisia)
Thymic neoplasms: clinical presentation, diagnosis and management - A single institution experience D. Mursic (Zagreb, Croatia)
SOLITARY FIBROUS TUMOR OF THE PLEURA: OUR EXPERIENCE I. Jimenez Setuain (Burlada (Navarra), Spain)
Is the size of pleural effusion important in the study of patients whose first tumor manifestation is a pleural effusion? M. Perez Warnisher (Madrid, Spain)
Pleural fluid ‘cell block’ analysis in malignant pleural effusion: sensitive, superior over fluid cytology and suitable for immunohistochemistry analysis (IHC), will decrease need for thoracoscopy guided procedures P. Shital (Latur (Maharashtra), India)
Malignant pleural mesothelioma:a 16-year, single centre experience M. Brandão (Vila Nova de Gaia, Portugal)
Refining the breath fingerprint of mesothelioma patients by in vitro identification of cancer cell line-specific volatile metabolites S. Lagniau (Gent, Belgium)
The survival prediction of malignant pleural effusion and the validation of LENT prognosis score in Thai patients. P. Petborom (Nakhon Nayok, Thailand)
Role of rapid on-site evaluation (ROSE)-cytology of pleural crush biopsy samples in diagnostic pleuroscopy (medical thoracoscopy) for assessing requirement of pleurodesis in the same sitting in a TB endemic country K. Gera (FARIDABAD (HARYANA), India)